Sustained efficacy over 1 year of treatment with erenumab: results from the extension phase of the STRIVE study in episodic migraine

被引：0
|
作者：
Goadsby, Peter J. [1 ]
Reuter, Uwe [2 ]
Hallstrom, Yngve [3 ]
Broessner, Gregor [4 ]
Bonner, Jo H. [5 ]
Zhang, Feng [6 ]
Sapra, Sandhya [6 ]
Chou, Denise E. [6 ]
Klatt, Jan [7 ]
Picard, Hernan [6 ]
Lenz, Robert A. [6 ]
Mikol, Daniel D. [6 ]
机构：
[1] Kings Coll Hosp London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[2] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[3] St Gorans Univ Hosp, Neuro Ctr, Stockholm, Sweden
[4] Med Univ Innsbruck, Headache Outpatient Clin, Dept Neurol, Innsbruck, Austria
[5] Mercy Res, St Louis, MO USA
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
[7] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF HEADACHE AND PAIN | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P20
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sustained Efficacy Over 1 Year of Treatment With Erenumab: Results From the Extension Phase of the STRIVE Study in Episodic Migraine
    Chou, Denise E.
    Goadsby, Peter J.
    Reuter, Uwe
    Hallstrom, Yngve
    Broessner, Gregor
    Bonner, Jo H.
    Zhang, Feng
    Sapra, Sandhya
    Klatt, Jan
    Picard, Hernan
    Mikol, Daniel D.
    [J]. NEUROLOGY, 2019, 92 (15)
  • [2] Sustained Efficacy over 1 Year of Treatment with Erenumab: Results from the Extension Phase of the STRIVE Study in Episodic Migraine
    Goadsby, P. J.
    Hallstrom, Y.
    Broessner, G.
    Bonner, J. H.
    Zhang, F.
    Sapra, S.
    Chou, D. E.
    Klatt, J.
    Pichard, H.
    Lenz, R. A.
    Mikol, D. D.
    [J]. HEADACHE, 2018, 58 (08): : 1313 - 1313
  • [3] One-year sustained efficacy of erenumab in episodic migraine Results of the STRIVE study
    Goadsby, Peter J.
    Reuter, Uwe
    Hallstroem, Yngve
    Broessner, Gregor
    Bonner, Jo H.
    Zhang, Feng
    Wright, Ian K.
    Chou, Denise E.
    Klatt, Jan
    Picard, Hernan
    Lenz, Robert A.
    Mikol, Daniel D.
    [J]. NEUROLOGY, 2020, 95 (05) : E469 - E479
  • [4] SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Xue, Fei
    Zhang, Feng
    Cheng, Sunfa
    Chou, Denise E.
    Lima, Gabriel Paiva da Silva
    [J]. CEPHALALGIA, 2020, 40 : 60 - 61
  • [5] Efficacy outcomes in responder and nonresponder patients with episodic migraine treated preventively with erenumab in the STRIVE study
    Broessner, Gregor
    Reuter, Uwe
    Bonner, Jo H.
    Dodick, David W.
    Picard, Hernan
    Wen, Shihua
    Ritter, Shannon
    Klatt, Jan
    Mikol, Daniel D.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [6] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-Year, Open-Label Extension Study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Chou, D. E.
    Klatt, J.
    Xue, F.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    [J]. HEADACHE, 2019, 59 : 25 - 25
  • [7] Reducing the Impact of Migraine on Functioning: Results from the STRIVE Trial: A Phase 3, Randomized, Double-Blind Study of Erenumab in Subjects with Episodic Migraine
    Buse, Dawn C.
    Lipton, Richard B.
    Mikol, Daniel D.
    Thach, Andrew V.
    Desai, Pooja
    Picard, Hernan
    Kubo, Yumi
    Hareendran, Asha
    Kawata, Ariane K.
    [J]. CEPHALALGIA, 2017, 37 : 195 - 196
  • [8] Reducing impaired days: Results from the STRIVE trial, a phase 3, randomised, double-blind study of erenumab for episodic migraine
    Hareendran, Asha
    Buse, Dawn C.
    Lipton, Richard B.
    Bayliss, Martha S.
    Mikol, Daniel D.
    Revicki, Dennis A.
    Zhang, Feng
    Desai, Pooja
    Picard, Hernan
    Kawata, Ariane K.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [9] Reducing Impaired Days: Results from the STRIVE Trial, A Phase 3, Randomized, Double-Blind Study of Erenumab for Episodic Migraine
    Hareendran, Asha
    Buse, Dawn C.
    Lipton, Richard B.
    Bayliss, Martha S.
    Mikol, Daniel D.
    Revicki, Dennis A.
    Zhang, Feng
    Desai, Pooja
    Picard, Hernan
    Kawata, Ariane K.
    [J]. CEPHALALGIA, 2017, 37 : 275 - 276
  • [10] Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials
    Kawata, Ariane K.
    Ladd, Mary Kate
    Lipton, Richard B.
    Buse, Dawn C.
    Bensink, Mark
    Shah, Shweta
    Hareendran, Asha
    Mannix, Sally
    Mikol, Daniel
    [J]. HEADACHE, 2022, 62 (02): : 159 - 168
12345